Sickness Syndrome Depression Discovery
Dr. Gina L. Nick, President of the California Naturopathic Doctors Association, practicing Naturopathic Medical Doctor, and leading integrative medical research scientist, identified Sickness Syndrome depression and the mechanisms involved that link inflammation in the brain to depression.
Dedicating the past ten years to researching the relationship between stress, inflammation and depression, Dr. Nick, in an unexpected and inspired series of medical discoveries, identified the mechanisms involved in Sickness Syndrome depression.
The incidence of Sickness Syndrome depression was first noted when patients treated with recombinant cytokines as an immunotherapy displayed mood disorders and cognitive disturbances atypical of the symptoms of the sickness being treated.
These non-specific symptoms are directly caused by peripheral inflammatory cytokines that trigger the local production of inflammatory cytokines in the brain, namely IL-1 and TNF alpha
, and most often specifically develop in patients suffering from somatic diseases with an inflammatory component such as cancer, coronary heart disease, rheumatoid arthritis, asthma, cancer, stroke and various neuropathologies.
However Dr. Nick also discovered that Sickness Syndrome can be triggered by other illnesses and conditions, such as chronic stress, adrenal fatigue, blood sugar imbalance, obesity, infection, and estrogen deficiency, all of which increase the production of peripheral inflammatory cytokines and weaken the body’s ability to function at its optimum level.
Listen to scientific presentations and published research articles by Dr. Nick regarding the appropriate diagnosis and treatment of this prevalent cause of depression and anxiety in a large subset of the population.
2 Kelley KW, et al. Cytokine-induced sickness behavior. Brain Behav Immun. 2003 Feb;17 Suppl 1:S112-8.(back)
3 Cleeland et al. Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokineimmunologic model of cancer symptoms. Cancer 2003. 97:2919–2925.(back)
4 Gidron Y, Gilutz H, Berger R, Huleihel M. Molecular and cellular interface between behavior and acute coronary syndromes. Cardiovasc Res. 2002 Oct;56(1):15-21.(back)
5 Kiecolt-Glaser JK, Glaser R. Depression and immune function: central pathways to morbidity and mortality. J Psychosom Res. 2002 Oct;53(4):873-6.(back)
6 Hellhammer J, Schlotz W, Stone AA, Pirke KM, Hellhammer D. Allostatic load, perceived stress, and health: a prospective study in two age groups. Ann N Y Acad Sci. 2004 Dec;1032:8-13.(back)
7 Suarez EC, et al. Increases in stimulated secretion of proinflammatory cytokines by blood monocytes following arousal of negative affect: the role of insulin resistance as moderator. Brain Behav Immun. 2006 Jul;20(4):331-8.(back)
8 Lee YH, Pratley RE. The evolving role of inflammation in obesity and the metabolic syndrome.Curr Diab Rep. 2005 Feb;5(1):70-5.(back)
9 Bluthé RM, et al. Effects of insulin-like growth factor-I on cytokine-induced sickness behavior in mice. Brain, Behavior, and Immunity 2006; 57–63.(back)
10 Czlonkowska A, Ciesielska A, Gromadzka G, Kurkowska-Jastrzebska I. Gender differences in neurological disease: role of estrogens and cytokines. Endocrine 2006 Apr;29(2):243-56.(back)
11 Czlonkowska A, Ciesielska A, Gromadzka G, Kurkowska-Jastrzebska I. Estrogen and cytokines production - the possible cause of gender differences in neurological diseases. Curr Pharm Des. 2005;11(8):1017-30.(back)